Cite

HARVARD Citation

    Lozeron, P. et al. (2016). Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease. Muscle & nerve. 53 (5), pp. 683-689. [Online]. 
  
Back to record